“…Since then, more recent studies not only corroborated, but have extended their reports by finding new active components and their modes of actions. After an exhaustive review of studies and reports, the following represent the VA and SLs' anticancer activity literature: Many SLs (vernomydaline, vernolide, vernodaline, vernolepin, helenalin, elephantopin, eriofertopin, psilostachyins A, psilostachyins C, 2,3-dihydrohelenalin, bis-helenalinyl malonate, parthenolid, telekin, artemisinin, ergolide, Cynaropicrin and others) have been identified as anticancer agents [12][13][14][15][16][17][18][19][20][21][22]. (Fig.…”